Congress extends federal funding temporarily
This article was originally published in The Tan Sheet
Executive Summary
Congress Sept. 30 passes a continuing resolution maintaining funding for FDA and other federal agencies at fiscal 2010 levels. The CR expires Dec. 3. If Republicans win a majority in the midterm elections in November, during the subsequent lame-duck session they might force passage of another CR that would the allow the party to set fiscal 2011 spending levels after the 112th Congress begins in January
You may also be interested in...
FDA Strategic Documents Outline Regulatory Science Priorities
Improving regulatory tools and scientific know-how are among FDA's top priorities over the next five years, according to a draft strategic report
2022 Korean VC Financings Led By Mid-Stage Bioventures
Amid a generally harsh environment, venture capital investors in South Korea appeared to take a more selective approach in 2022, with more established and financially stable domestic bioventures the biggest beneficiaries.
New COVID Treatments Face FDA, Commercial Barriers Despite Ongoing Need
Sponsors want more endpoint clarity as current state of government pandemic response, along with scientific and regulatory hurdles, is constraining efforts to refill a shrinking COVID medicine cabinet and could create vulnerabilities for future pandemics.